Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Prokarium

Request full access

Oral vaccines for infectious diseases

London, United KingdomFounded 2012Biotech & Life Sciences

About Prokarium

Prokarium is a biopharmaceutical company that is a leader in the oncology field of microbial immunotherapy. The company's pipeline is designed to advance immuno-oncology by building on the most recent advances in the field. Prokarium's lead program is currently in clinical trials for bladder cancer.

Prokarium's mission is to create novel cancer treatments by applying synthetic biology. The company is also developing oral and thermostable vaccines against Chlamydia trachomatis, a sexually transmitted infection.

Prokarium's business model is focused on the development and commercialization of its proprietary technology platform. The company's target clients are patients with cancer and other diseases that can be treated with microbial immunotherapy.

Source: Dealroom company data

At a glance

Status
Operational
Employees
18
Open positions
None listed
Dealroom signal
72.6/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Vaccines, Genetics and genomics, Immune System, Synthetic Biology, Biotech and Pharma, BIA Techbio UK, Techbio
Business model
Manufacturing
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEOther financing Dec 2025 $6.3M — Flerie Invest ↗
GRANTOther financing Aug 2024 $419K — UK Research and Innovation —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Prokarium website traffic

Latest recorded traffic for Prokarium is 1.1K monthly website visits, up 340% over the last three months. Prokarium's team grew 0% over the past year.

Latest monthly visits1.1K 3-month web change+340% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Prokarium in the London ecosystem

Live from Dealroom

The Prokarium office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Flerie Invest
  • Biotechnology and Biological Sciences Research Council (BBSRC)
  • UK Research and Innovation

Series A4 investors entered at this stage

  • Riyadh Valley Company
  • Korea Investment Partners
  • Wellcome Trust
  • Future Fund

Other known investors1 additional known investor

  • SynbiCITE
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇬🇧 United Kingdom75%
🇩🇪 Germany5%
🇺🇸 United States5%
🇨🇭 Switzerland5%
🇩🇰 Denmark5%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Prokarium on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prokarium’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.